2028년까지 아시아 태평양 인간 간 모델 시장 예측 – 유형별(간 유기체, 간 칩, 2D 모델, 3D 바이오프린팅 등), 애플리케이션(약물 발견, 교육 등)별 코로나19 영향 및 지역 분석 ) 및 최종 사용자(제약 및 생명공학 회사, 연구소 및 기타)

TIPRE00026111 | Pages: 112 | Biotechnology | Nov 2021 | Type: Regional | Status: Published
APAC 인간 간 모델 시장은 2021년 33,191.56,000달러에서 2028년까지 76,341,400달러로 성장할 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 12.6%로 성장할 것으로 예상됩니다.\\n\\n중국, 일본, 인도, 한국, 호주는 APAC의 주요 경제국입니다. 신약 발견 활동에 대한 관심이 높아지면서 시장 성장이 가속화될 것으로 예상됩니다. 임상시험에서 신약을 시험하기 전, 동물 모델과 2차원(2D) in vitro 모델을 활용하여 약력학 및 약동학에 대한 주요 단계 분석을 수행합니다. 단일 의약품을 시장에 출시하는 데는 1215년, 미화 350억 달러가 소요됩니다. 신약 및 첨단 약물에 대한 수요 증가로 인해 약물 발견 및 발견의 일반적인 속도가 빨라지고 있습니다. 이에 따라 신약을 개발하고 상용화하기 위해 많은 임상 연구가 진행되고 있다. 시장 출시(4단계) 후에도 독성학적 이유로 인해 여전히 많은 약물 중단이 발생하고 있습니다. 이러한 중단 중 약 1,830%는 간독성 효과로 인한 것이며, 이는 간이 약물유해반응(ADR)의 가장 일반적인 표적임을 보여줍니다. 간은 약물 대사, 신체 항상성, 소화 및 독성 물질 배설에 중요한 역할을 합니다. 간의 경우, 약물 발견을 위한 가장 간단한 모델은 약물 대사 효소(DME) 또는 분리된 미토콘드리아를 포함하는 마이크로솜과 같은 분리된 세포하 분획입니다. 높은 민감도와 특이성을 가능하게 하려면 세포 기반 모델이 고차 약물 과정(즉, 생체변환, 수송 동역학, 2차 대사산물 형성 및 약물 상호작용(DDI))을 복제해야 합니다. 인간 간 모델은 화합물과 약물의 신진대사와 독성을 평가하고, 암 연구 및 유전학 연구에서 약물 후보를 평가하는 데 사용됩니다. 임상 시험의 상당한 증가는 오가노이드 모델을 포함한 첨단 의료 기술에 대한 수요를 촉진하여 APAC 시장 성장을 촉진할 것으로 예상됩니다.\\n\\nAPAC 바이오제약 산업은 2020년 코로나19가 발생하는 동안 몇 달 동안 혼란을 겪었습니다. . 코로나19 팬데믹으로 인해 감염 확산을 통제하기 위한 제한 조치로 인해 임상시험이 중단되었습니다. 그러나 코로나19 감염 치료 제품에 대한 수요가 증가하면서 인도와 중국의 바이오제약·제약회사들은 계속해서 연구 활동에 집중했다. 예를 들어, 2020년 2월 Vir Biotechnology(미국)는 WuXi Biologics(중국)와 제휴하여 코로나19 감염을 치료하기 위한 인간 단일클론 항체를 개발했습니다. 이번 파트너십에는 임상 개발, 제조, 상업화가 포함되며, WuXi Biologics는 임상 개발을 위한 공정 및 제제 개발과 초기 생산을 담당하게 됩니다. 더욱이 이 지역 기업들은 코로나19 백신 개발에 집중하기 위해 핵심 활동을 보류했다. 예를 들어, 2020년 3월 생명공학 CRO Novotech(호주)는 코로나19의 잠재적 치료법인 Panaphix의 임상 시험을 위해 Komipharm International(한국)과 파트너십을 맺었습니다. 최근 코로나19 발병에 대응하여 많은 국가에서 부과한 제한 사항이 진행 중인 임상 연구에 영향을 미쳤습니다. \\n\\n새로운 기능과 기술을 통해 공급업체는 새로운 고객을 유치하고 신흥 시장에서 입지를 확장할 수 있습니다. 이 요인은 APAC 인간 간 모델 시장을 주도할 가능성이 높습니다. APAC 인간 간 모델 시장은 예측 기간 동안 좋은 CAGR로 성장할 것으로 예상됩니다. \\n\\nAPAC 인간 간 모델 시장 수익 및 2028년 예측(미화 천 달러) \\n\\nAPAC 인간 간 모델 시장 세분화 \\nAPAC 인간 간 모델 시장 유형별\\n- 간 오가노이드\\n- 간 칩 \\n- 2D 모델\\n- 3D 바이오 프린팅\\n- 기타\\n응용 분야별 APAC 인간 간 모델 시장\\n- 신약 개발\\n- 교육\\n- 기타\\n최종 사용자별 APAC 인간 간 모델 시장\\n- 제약 및 생명공학 회사\\n- 연구소 \\n- 기타 \\n국가별 APAC 인간 간 모델 시장\\n- 일본 \\n- 중국\\n- 인도\\n- 한국 \\n- 호주\\n- 나머지 APAC\\nAPAC 인간 간 모델 시장 - 언급된 회사 \\n- BioIVT\\n- CELLINK\\n- CYFUSE BIOMEDICAL KK\\n- Emulate, Inc.\\n- InSphero\\n- Kerafast\\n- MIMETAS BV\\n- THERMO FISHER SCIENTIFIC INC.\\n\\ N
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Human Liver Models Market By Type
1.3.2 APAC Human Liver Models Market By Application
1.3.3 APAC Human Liver Models Market By End User
1.3.4 APAC Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Human Liver Models Market Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Liver Diseases
5.1.2 Growing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 High Costs of Liver Models
5.3 Market Opportunities
5.3.1 Increasing focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Technology Advancements in Organ Printing
5.1 Impact analysis
6. Human Liver Models Market APAC Analysis
6.1 APAC Human Liver Models Market Revenue Forecast and Analysis
7. APAC Human Liver Models Market Analysis By Type
7.1 Overview
7.2 APAC Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. APAC Human Liver Models Market Analysis By Application
8.1 Overview
8.2 APAC Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. APAC Human Liver Models Market Analysis By End User
9.1 Overview
9.2 APAC Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. APAC Human Liver Models Market Country Analysis
10.1 APAC: Human Liver Models Market
10.1.1 Overview
10.1.2 APAC: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.1.1 China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.1.2 China: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.1.3 China: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.1.4 China: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.2 Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.2.1 Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.2.2 Japan: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.2.3 Japan: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.2.4 Japan: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.3 India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.3.1 India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.3.2 India: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.3.3 India: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.3.4 India: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.4 Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.4.1 Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.4.2 Australia: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.4.3 Australia: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.4.4 Australia: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.5 South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.5.1 South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.5.2 South Korea: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.5.3 South Korea: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.5.4 South Korea: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.6 Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.6.1 Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.6.2 Rest of APAC: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.6.3 Rest of APAC: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.6.4 Rest of APAC: Human Liver Models Market, by End User, 20192028 (USD Thousand)
11. Impact Of COVID-19 Pandemic on APAC Human Liver Models Market
11.1 APAC: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CYFUSE BIOMEDICAL K.K.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MIMETAS BV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 InSphero
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioIVT
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 CELLINK
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Kerafast
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms


LIST OF TABLES
Table 1. APAC Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. China: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 3. China: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 4. China: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 5. Japan: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 6. Japan: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 7. Japan: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 8. India: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 9. India: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 10. India: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 11. Australia: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 12. Australia: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 13. Australia: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 14. South Korea: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 15. South Korea: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 16. South Korea: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 17. Rest of APAC: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 18. Rest of APAC: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 19. Rest of APAC: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms


LIST OF FIGURES
Figure 1. APAC Human Liver Models Market Segmentation
Figure 2. APAC Human Liver Models Market Segmentation, By Country
Figure 3. APAC Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. APAC PEST Analysis
Figure 7. APAC Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. APAC Human Liver Models Market Revenue Forecast and Analysis
Figure 9. APAC Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. APAC Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. APAC Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. APAC 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. APAC 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. APAC Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. APAC Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. APAC Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. APAC Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. APAC Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. APAC Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. APAC Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. APAC Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. APAC Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. APAC: Human Liver Models Market, by Key Country Revenue (2021) (USD Thousand)
Figure 24. APAC: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 26. Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 27. India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 28. Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 29. South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 30. Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 31. Impact of COVID-19 Pandemic in APAC Country Markets

1. BioIVT
2. CELLINK
3. CYFUSE BIOMEDICAL K.K.
4. Emulate, Inc.
5. InSphero
6. Kerafast
7. MIMETAS BV
8. THERMO FISHER SCIENTIFIC INC.

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC human liver models market. - Highlights key business priorities in order to assist companies to realign their business strategies - The key findings and recommendations highlight crucial progressive industry trends in the APAC human liver models market, thereby allowing players across the value chain to develop effective long-term strategies - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets - Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000